. There was no evidence of an effect in women who had used oral contraceptives for less then 4 years, but the data were compatible with a steady increase in breast cancer risk with increasing duration of oral contraceptive use. Other studies of young women have found similar effects (see review by La Vecchia, 1992) although no increased risk is reported from studies of older women. A question frequently asked by doctors involved in family planning is whether these risks are modified by the pattern of oral contraceptive use, and in particular whether continuous use is more harmful than intermittent use.
The UK National Case-Control Study was set up to investigate the relationship between oral contraceptive use and breast cancer risk in young women. We found evidence of a relationship between oral contraceptive use and breast cancer risk with a highly significant trend (P<0.001) with duration of use and relative risks of 1.43 [95% confidence interval (CI) 0.97-2.12] for 49-96 months use and 1.74 (95% CI 1.15-2.62) for 97 or more months use (UKNCCSG, 1989) . There was no evidence of an effect in women who had used oral contraceptives for less then 4 years, but the data were compatible with a steady increase in breast cancer risk with increasing duration of oral contraceptive use. Other studies of young women have found similar effects (see review by La Vecchia, 1992) although no increased risk is reported from studies of older women. A question frequently asked by doctors involved in family planning is whether these risks are modified by the pattern of oral contraceptive use, and in particular whether continuous use is more harmful than intermittent use.
Materials and methods
The study protocol and the statistical methods used have been described in detail (UKNCCSG, 1989 We defined patterns of oral contraceptive use as follows: the dates of first and last use of oral contraceptives were known for each woman; if use had been uninterrupted between those dates except for a maximum of 2 months off oral contraceptives, use was defined as continuous (31 women had a gap of 1 month and 34 a gap of 2 months); if use was interrupted only by one or more pregnancies and the interruption of oral contraceptive use for each pregnancy was the time actually pregnant plus not more than a total of 6 months (for example 3 months before becoming pregnant and 3 months after delivery), then use was defined as 'interrupted only by pregnancy'; all other use was defined as 'intermittent'.
Results
The numbers of cases and controls in the three subgroups of use with relative risks (RR) and 95% confidence intervals are shown in Table I significant. The relative risks per year of use were, however, similar in the three groups (1.07, 1.07 and 1.05 in continuous, interrupted and intermittent users respectively). An analysis allowing no breaks in use for uninterrupted users was also carried out and gave almost identical results.
Discussion
The relative risks per year of use in the three groups were very similar, and the test for heterogeneity showed no evidence of a difference in risk. Thus, although the relative risk for continuous oral contraceptive use for more than 8 years is higher than for the other two groups, this difference may well be due to chance. The relative risks for intermittent long-term use or long-term use interrupted only by pregnancy are very similar. These data thus provide little evidence that the relationship between total duration of oral contraceptive use and breast cancer risk found in the UK National Study (UKNCCSG, 1989 ) is modified by the pattern of use. It is important to note that the UK National Study results were confined to women diagnosed with breast cancer when very young (less than 36 years) and that most of these women had begun to use oral contraceptives before the age of 25. Most long-term oral contraceptive use was of the older high-dose pills, and we have previously reported some evidence that the modern lower dose pills may be less harmful (UKNCCSG, 1989) . Subgroup analyses which investigated possible high-risk groups (UKNCCSG, 1990) indicated no sub-group with a statistically significant modification of oral contraceptive-associated breast cancer risk. Attention was, however, drawn to the higher risks in women with a family history of breast cancer in a first-degree relative, and to the likelihood that the effects of oral contraceptive use and of having such a family history are multiplicative. In the absence of any substantial evidence that interruption of oral contraceptive use diminishes the increased risk of breast cancer in young women found in long-term oral contraceptive users (La Vecchia, 1992) , the timing of oral contraceptive use should be determined primarily by the need for maximal contraceptive efficacy, which for most women is likely to be before the first pregnancy.
